Paper32802408
Correction: AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing.
Sahin I and 6 others. Cell Death Discov, 2020. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Correction: AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing. Papers, record 32802408. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32802408
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Correction: AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum for | 32655895 | AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing. | https://conductscience.org/library/papers/32655895 |
Source PubMed
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40211092 | A working group report from the 2024 National Cancer Institute / Gynecologic Cancer Steering Committee endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy era. | J Natl Cancer Inst | 2025 | https://conductscience.org/library/papers/40211092 | PubMed |
| 39253578 | Protein ubiquitination in ovarian cancer immunotherapy: The progress and therapeutic strategy. | Genes Dis | 2024 | https://conductscience.org/library/papers/39253578 | PubMed |
| 38476371 | The role of immunotherapy sensitizers and novel immunotherapy modalities in the treatment of cancer. | Front Oncol | 2024 | https://conductscience.org/library/papers/38476371 | PubMed |
| 36899853 | RUNX3 Meets the Ubiquitin-Proteasome System in Cancer. | Cells | 2023 | https://conductscience.org/library/papers/36899853 | PubMed |
| 35765530 | AMG-232, a New Inhibitor of MDM-2, Enhance Doxorubicin Efficiency in Pre-B Acute Lymphoblastic Leukemia Cells. | Rep Biochem Mol Biol | 2022 | https://conductscience.org/library/papers/35765530 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MDM2 | 4193 | PubTator's text mining | https://conductscience.org/library/genes/4193 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32802408
GET https://conductscience.org/api/papers/v1/32802408/authors